Good Morning All,
Thought this might be of some use.
the article.
Oxford BioMedica (Oxford, UK) have developed a technology that
might eventually
allow a patient's own macrophages to deliver anti-cancer genes to
solid tumours. A
recently published proof-of-concept study 1 involving an in vitro
model of solid
tumours marks the first use of macrophages to selectively deliver
therapies to hypoxic
regions in tumours.
God Bless You All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
